Wang Jiaxing, Li Jinhua, Qian Shi, Guo Geyong, Wang Qiaojie, Tang Jin, Shen Hao, Liu Xuanyong, Zhang Xianlong, Chu Paul K
Department of Orthopaedics, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai Jiao Tong University , Shanghai 200233, China.
State Key Laboratory of High Performance Ceramics and Superfine Microstructure, Shanghai Institute of Ceramics, Chinese Academy of Sciences , Shanghai 200050, China.
ACS Appl Mater Interfaces. 2016 May 4;8(17):11162-78. doi: 10.1021/acsami.6b02803. Epub 2016 Apr 19.
Periprosthetic joint infection (PJI) is one of the formidable and recalcitrant complications after orthopedic surgery, and inhibiting biofilm formation on the implant surface is considered crucial to prophylaxis of PJI. However, it has recently been demonstrated that free-floating biofilm-like aggregates in the local body fluid and bacterial colonization on the implant and peri-implant tissues can coexist and are involved in the pathogenesis of PJI. An effective surface with both contact-killing and release-killing antimicrobial capabilities can potentially abate these concerns and minimize PJI caused by adherent/planktonic bacteria. Herein, Ag nanoparticles (NPs) are embedded in titania (TiO2) nanotubes by anodic oxidation and plasma immersion ion implantation (PIII) to form a contact-killing surface. Vancomycin is then incorporated into the nanotubes by vacuum extraction and lyophilization to produce the release-killing effect. A novel clinical PJI model system involving both in vitro and in vivo use of methicillin-resistant Staphylococcus aureus (MRSA) ST239 is established to systematically evaluate the antibacterial properties of the hybrid surface against planktonic and sessile bacteria. The vancomycin-loaded and Ag-implanted TiO2 nanotubular surface exhibits excellent antimicrobial and antibiofilm effects against planktonic/adherent bacteria without appreciable silver ion release. The fibroblasts/bacteria cocultures reveal that the surface can help fibroblasts to combat bacteria. We first utilize the nanoarchitecture of implant surface as a bridge between the inorganic bactericide (Ag NPs) and organic antibacterial agent (vancomycin) to achieve total victory in the battle of PJI. The combination of contact-killing and release-killing together with cell-assisting function also provides a novel and effective strategy to mitigate bacterial infection and biofilm formation on biomaterials and has large potential in orthopedic applications.
人工关节感染(PJI)是骨科手术后严重且棘手的并发症之一,抑制植入物表面生物膜形成被认为对预防PJI至关重要。然而,最近有研究表明,局部体液中游离的生物膜样聚集体与植入物及植入物周围组织上的细菌定植可同时存在,并参与PJI的发病机制。具有接触杀灭和释放杀灭抗菌能力的有效表面可能会减轻这些问题,并将粘附/浮游细菌引起的PJI降至最低。在此,通过阳极氧化和等离子体浸没离子注入(PIII)将银纳米颗粒(NPs)嵌入二氧化钛(TiO2)纳米管中,形成接触杀灭表面。然后通过真空萃取和冻干将万古霉素掺入纳米管中,以产生释放杀灭效果。建立了一种新型临床PJI模型系统,该系统同时在体外和体内使用耐甲氧西林金黄色葡萄球菌(MRSA)ST239,以系统评估这种复合表面对浮游细菌和固着细菌的抗菌性能。负载万古霉素并植入银的TiO2纳米管表面对浮游/粘附细菌表现出优异的抗菌和抗生物膜效果,且没有明显的银离子释放。成纤维细胞/细菌共培养显示,该表面可帮助成纤维细胞对抗细菌。我们首次利用植入物表面的纳米结构作为无机杀菌剂(Ag NPs)和有机抗菌剂(万古霉素)之间的桥梁,以在PJI的战斗中取得全面胜利。接触杀灭和释放杀灭与细胞辅助功能的结合还提供了一种新颖有效的策略,以减轻生物材料上的细菌感染和生物膜形成,在骨科应用中具有巨大潜力。